Clinical Trial

Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial

Recruiting
View on ClinicalTrials.gov →
Summary
Randomized, controlled study consisting of three parallel arms to investigate the effects of novel infant formula on growth, gut health, immune function, and sleep status in healthy infants and young children aged 12-18 months.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-17
Trial Details
NCT Number NCT07534735
Lead Sponsor Biostime (Changsha) Nutrition Foods Limited
Collaborators: Shenzhen University
Conditions Infant Growth
Enrollment 120 participants
Start Date 2026-05-27
Primary Completion 2026-10 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16